|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | A61K 39/09 | (2006.01) |
| (11) | Number of the document | 3017827 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15195398.1 |
| Date of filing the European patent application | 2006-12-20 | |
| (97) | Date of publication of the European application | 2016-05-11 |
| (45) | Date of publication and mention of the grant of the patent | 2018-11-07 |
| (46) | Date of publication of the claims translation | 2019-01-10 |
| (30) | Number | Date | Country code |
| 0526232 | 2005-12-22 | GB | |
| 0607087 | 2006-04-07 | GB | |
| 0607088 | 2006-04-07 | GB | |
| 0609902 | 2006-05-18 | GB | |
| 0620336 | 2006-10-12 | GB | |
| 0620337 | 2006-10-12 | GB | |
| 0620815 | 2006-10-19 | GB | |
| 0620816 | 2006-10-19 | GB | |
| PCT/GB2006/0046 | 2006-12-12 | WO |
| (72) |
BIEMANS, Ralph Leon, BE
GARCON, Nathalie Marie-Josephe, BE
HERMAND, Philippe Vincent, BE
POOLMAN, Jan, BE
VAN MECHELEN, Marcelle Paulette, BE
|
| (73) |
GlaxoSmithKline Biologicals s.a.,
rue de l`Institut 89, 1330 Rixensart,
BE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Pneumokokinė polisacharidinė konjuguota vakcina |
| PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE |
| Payment date | Validity (years) | Amount | |
| 2024-11-21 | 19 | 347.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2025-04-01 |